Atrium Medical Recalls Advanta VS Grafts Due to Label Adhesion Issue
Atrium Medical Corporation is recalling Advanta VS Grafts because the inner tray label may adhere to the outer tray, making removal difficult.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a packaging/labeling issue that makes removal difficult but does not explicitly report injuries or serious health consequences, fitting the Moderate criteria for minor labeling or packaging issues.
Plain-English summary
Atrium Medical Corporation is recalling Advanta VS Grafts, which are intended for use in arterial vascular reconstruction, segmental bypass, and arteriovenous vascular access. The recall involves products manufactured between April 3, 2012, and May 14, 2013, with expiration dates between April 2017 and May 2018.
The recall was initiated because the inner tray label may adhere to the wall of the outer tray. This adhesion makes it difficult to remove the tray onto the sterile field. The affected products were distributed nationwide in the United States and internationally to numerous countries.
Healthcare facilities and distributors should stop using the affected products and contact Atrium Medical Corporation for further instructions. The FDA has classified this recall as Class II, indicating a reasonable probability that the use of the product could cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Advanta VS Grafts <6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
- Manufacturer
- Atrium Medical Corporation
- Category
- Medical Device — Vascular Grafts
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Product manufactured between April 3
- 2012 and May 14
- 2013 and can be identified by their expiration date
- between April 2017 and May 2018.
Distribution
Part of a larger recall action
This product is one of 14 recalled by Atrium Medical Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Atrium Medical Corporation
See all →- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- ModerateiCast Covered Stent Recalled for Unique Device Identifier Labeling Error
FDA (Devices) · 2024-10-16
- HighVascular graft component separation reported in Advanta VXT devices
FDA (Devices) · 2024-06-12
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- HighAdvanta VXT vascular grafts recalled for swivel rod separation
FDA (Devices) · 2024-06-12
- HighVascular Graft Recalled Due to Swivel Rod Separation Risk
FDA (Devices) · 2024-06-12
- HighVascular Graft Swivel Rod Separation Recalled Due to Component Failure
FDA (Devices) · 2024-06-12
- HighAtrium ADVANTA VXT Vascular Graft may lack required radial support ring
FDA (Devices) · 2021-10-06
- HighVascular Graft Recall for Component Separation in ADVANTA VXT
FDA (Devices) · 2024-06-12
- HighVascular graft recalled due to slider component separation risk
FDA (Devices) · 2024-06-12